5.60
price up icon15.94%   0.77
pre-market  Vorhandelsmarkt:  5.60  
loading
Schlusskurs vom Vortag:
$4.83
Offen:
$4.86
24-Stunden-Volumen:
250.75K
Relative Volume:
2.90
Marktkapitalisierung:
$15.86M
Einnahmen:
$755.00K
Nettoeinkommen (Verlust:
$-9.33M
KGV:
-0.9807
EPS:
-5.71
Netto-Cashflow:
$-5.43M
1W Leistung:
+23.89%
1M Leistung:
+114.56%
6M Leistung:
+24.44%
1J Leistung:
+68.47%
1-Tages-Spanne:
Value
$4.7404
$5.60
1-Wochen-Bereich:
Value
$4.25
$5.60
52-Wochen-Spanne:
Value
$2.07
$16.80

Mangoceuticals Inc Stock (MGRX) Company Profile

Name
Firmenname
Mangoceuticals Inc
Name
Telefon
(833) 626-4679
Name
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MGRX's Discussions on Twitter

Vergleichen Sie MGRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
MGRX
Mangoceuticals Inc
5.60 15.86M 755.00K -9.33M -5.43M -5.71
Health Information Services icon
VEEV
Veeva Systems Inc
229.19 37.21B 2.66B 665.91M 1.08B 4.05
Health Information Services icon
DOCS
Doximity Inc
76.68 14.39B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
85.71 13.49B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
SOLV
Solventum Corp
73.98 12.78B 8.26B 66.00M 1.17B 0.3682
Health Information Services icon
HQY
Healthequity Inc
113.78 9.86B 1.15B 96.70M -161.99M 1.09

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

pulisher
Feb 19, 2025

Mangoceuticals Inc. issues stock for consulting services - Investing.com

Feb 19, 2025
pulisher
Feb 19, 2025

Mangoceuticals (MGRX): A Low Float Stock on the Verge of a Short Squeeze? - Small Cap Exclusive

Feb 19, 2025
pulisher
Feb 19, 2025

Mangoceuticals (NASDAQ:MGRX) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Analysis - Defense World

Feb 19, 2025
pulisher
Feb 14, 2025

Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com Nigeria

Feb 14, 2025
pulisher
Feb 14, 2025

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution - Marketscreener.com

Feb 14, 2025
pulisher
Feb 14, 2025

Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World

Feb 14, 2025
pulisher
Feb 13, 2025

Mangoceuticals targets avian flu with water-based solution - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com

Feb 12, 2025
pulisher
Feb 12, 2025

Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire

Feb 12, 2025
pulisher
Feb 12, 2025

Revolutionary Water-Based Solution Shows Promise in Fighting Bird Flu CrisisPhase I Results Reveal Major Breakthrough - StockTitan

Feb 12, 2025
pulisher
Feb 10, 2025

Mangoceuticals Inc (MGRX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Feb 10, 2025
pulisher
Feb 08, 2025

Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts - Small Cap Exclusive

Feb 08, 2025
pulisher
Feb 07, 2025

Mangoceuticals Expands COO Role and Increases Compensation - TipRanks

Feb 07, 2025
pulisher
Feb 06, 2025

Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire

Feb 06, 2025
pulisher
Feb 06, 2025

Mangoceuticals advances in H1N1 and H5N1 studies - Investing.com

Feb 06, 2025
pulisher
Feb 06, 2025

Mangoceuticals advances in H1N1 and H5N1 studies By Investing.com - Investing.com UK

Feb 06, 2025
pulisher
Feb 06, 2025

Major H1N1 Treatment Success: Mangoceuticals' Novel Antiviral Shows Promise Against Bird Flu - StockTitan

Feb 06, 2025
pulisher
Feb 06, 2025

Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research - Business Upturn

Feb 06, 2025
pulisher
Feb 03, 2025

Mangoceuticals executes exclusive distribution agreement with Propre - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Mangoceuticals Signs Exclusive Distribution Deal With Propre Energie For Dermytol - Nasdaq

Feb 03, 2025
pulisher
Feb 03, 2025

Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com

Feb 03, 2025
pulisher
Jan 26, 2025

Mangoceuticals, Inc. Announces Closing of $5 Million Initial Public Offering - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 25, 2025

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 21, 2025

Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments - TipRanks

Jan 21, 2025
pulisher
Jan 18, 2025

Mangoceuticals alters stockholder rights, amends bylaws - MSN

Jan 18, 2025
pulisher
Jan 16, 2025

Mangoceuticals alters stockholder rights, amends bylaws By Investing.com - Investing.com Canada

Jan 16, 2025
pulisher
Jan 10, 2025

Mangoceuticals, Inc. announced that it has received $0.55 million in funding - Marketscreener.com

Jan 10, 2025
pulisher
Jan 09, 2025

Mangoceuticals, Inc. announced that it has received $0.05 million in funding - Marketscreener.com

Jan 09, 2025
pulisher
Jan 09, 2025

Mangoceuticals, Inc. announced that it has received $0.3 million in funding - Marketscreener.com

Jan 09, 2025
pulisher
Jan 09, 2025

Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors - Defense World

Jan 09, 2025
pulisher
Dec 27, 2024

Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Accredited Investors - Defense World

Dec 27, 2024
pulisher
Dec 20, 2024

Patent Acquisition Fuels Mangoceuticals (MGRX) Stock Surge During Extended Trading - Stocks Telegraph

Dec 20, 2024
pulisher
Dec 19, 2024

Mangoceuticals Shares Rise 22%, Company Acquires Mushroom-Based Wellness and Innovations Patent - MarketWatch

Dec 19, 2024
pulisher
Dec 19, 2024

Mangoceuticals Expands with Patent Acquisition in Nutraceuticals - TipRanks

Dec 19, 2024
pulisher
Dec 19, 2024

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewswire

Dec 19, 2024
pulisher
Dec 07, 2024

Mangoceuticals inks new service agreement, issues equity By Investing.com - Investing.com Nigeria

Dec 07, 2024
pulisher
Dec 07, 2024

Mangoceuticals inks new service agreement, issues equity - Investing.com India

Dec 07, 2024
pulisher
Dec 04, 2024

Mangoceuticals probes unusual stock activity post-split - Investing.com

Dec 04, 2024
pulisher
Dec 04, 2024

Mangoceuticals initiates investigation into potential stock manipulation - TipRanks

Dec 04, 2024
pulisher
Dec 04, 2024

Mangoceuticals probes unusual stock activity post-split By Investing.com - Investing.com UK

Dec 04, 2024
pulisher
Dec 04, 2024

Mangoceuticals, Inc. Initiates Investigation into Potential - GlobeNewswire

Dec 04, 2024
pulisher
Dec 04, 2024

MangoRx Launches Investigation Into Suspicious Trading Activity After Stock Split - StockTitan

Dec 04, 2024
pulisher
Nov 14, 2024

Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 12, 2024

Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World

Nov 12, 2024
pulisher
Nov 10, 2024

Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World

Nov 10, 2024

Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$14.03
price up icon 0.00%
$13.77
price up icon 5.03%
$25.50
price up icon 1.84%
$20.90
price down icon 5.64%
health_information_services WAY
$43.86
price down icon 2.77%
health_information_services HQY
$113.78
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):